Physician

Michael Ragosta, M.D.

According to 2025 Medicare claims, Michael Ragosta, M.D. (NPI: 1376609610) practices cardiology in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Charlottesville City, VA. This provider's primary affiliated billing organization is UNIVERSITY OF VIRGINIA PHYSICIANS GROUP (NPI: 1033138250; TIN: 541124769) and primary practice location at 22908-0816.

Ragosta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 621 traditional Medicare patients, billed 1,686 HCPCS/CPT codes, and received $218,366 in Medicare payments. The top billing code was 92928 (Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch). Part D data shows 1,484 prescription claims across 210 beneficiaries totaling $168,739 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 12 claims. Open Payments data shows 58 records totaling $317,388. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $50,712 to $168,739. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	721	1,435	$225,732
2016	747	1,540	$251,452
2017	795	2,072	$262,391
2018	851	2,297	$315,462
2019	893	2,340	$351,615
2020	725	1,998	$277,776
2021	680	1,875	$279,402
2022	677	1,704	$257,901
2023	687	1,625	$248,358
2024	621	1,686	$218,366

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	138	813	$50,712
2016	155	768	$50,558
2017	178	867	$61,547
2018	203	965	$59,061
2019	213	1,037	$62,364
2020	197	1,053	$69,940
2021	198	1,140	$69,152
2022	199	1,231	$117,445
2023	207	1,364	$146,897
2024	210	1,484	$168,739

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	30	$2,336
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$551
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92928	Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch	113	163	$363
92978	Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel	87	95	$70
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	285	312	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	89	89	$12
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	195	223	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	73	3,359	$61,345
Repatha Sureclick	Evolocumab	21	1,372	$25,613
Praluent Pen	Alirocumab	26	1,008	$17,355
Ranolazine Er	Ranolazine	32	2,073	$3,068
Symbicort	Budesonide/Formoterol Fumarate	13	390	$2,930

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$3,226	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	28	$314,161	University Of Virginia Medical Cente
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Ragosta, M.D.?

Tedicare shows public-source Medicare data for Michael Ragosta, M.D. (NPI 1376609610), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Ragosta, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Ragosta, M.D.?

Michael Ragosta, M.D. is linked to UNIVERSITY OF VIRGINIA PHYSICIANS GROUP (billing NPI 1033138250) in the available physician profile data.

Does Michael Ragosta, M.D. have Open Payments data?

Michael Ragosta, M.D. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.